Age-Related Alternative Splicing: Comparison
View Latest Version
Please note this is a comparison between Version 2 by Catherine Yang and Version 1 by Maurizio Romano.

Alternative splicing changes are closely linked to aging, though it remains unclear if they are drivers or effects. As organisms age, splicing patterns change, varying gene isoform levels and functions. These changes may contribute to aging alterations rather than just reflect declining RNA quality control. Three main splicing types—intron retention, cassette exons, and cryptic exons—play key roles in age-related complexity. These events modify protein domains and increase nonsense-mediated decay, shifting protein isoform levels and functions. This may potentially drive aging or serve as a biomarker. Fluctuations in splicing factor expression also occur with aging. Somatic mutations in splicing genes can also promote aging and age-related disease. 

  • aging
  • alternative splicing
  • senescence
  • age-related diseases
  • splicing factors

1. Introduction

A wide range of changes in cellular mechanisms involving both transcriptional and post-transcriptional regulation have been linked to normal aging [1]. While age-related variations in the cellular environment lead to eventual molecular changes, it is also possible that the molecular changes accelerate aging and age-related disorders (ranging from hypertension to cardiovascular disease, cancer, and neurodegeneration). Furthermore, different tissues and organs may experience different age-related alterations in transcriptional and post-transcriptional regulation.
In higher eukaryotic genomes, alternative splicing (AS) of both protein and non-coding genes not only profoundly contributes to increasing the functional diversity and complexity of the whole transcriptome [2[2][3][4],3,4], but it also seems to be a master regulator of cellular and individual aging.
Although the majority of variations in alternative splicing events occur during development, it is estimated that approximately 30% of all alternative splicing alterations occur during aging [5,6][5][6]. As rodents and humans consistently exhibit age- and tissue-related variations in the expression of genes involved in splicing [6,7[6][7][8][9][10][11],8,9,10,11], age-related changes in splicing may be caused by the age-related decline in splicing factor expression. On the other hand, the main categories of genes with age-related altered splicing include those encoding genes with neuronal-specific activities such as synaptic transmission in the human brain [11], as well as those implicated in collagen production and post-translational modification in the human Achilles tendon [12,13][12][13]. These observations suggest that age-dependent splicing changes are more likely to occur in at least some of the same categories of tissue-specific genes that show transcriptional decline with aging.
Aging-dependent splicing alterations can explain why some genes show a tissue-specific decrease in expression. Splicing errors during pre-mRNA processing can result in the incorrect usage of alternative splice sites, leading to intron retention in the mature mRNA transcript rather than proper exon joining. Intron retention introduces premature termination codons that target the aberrant transcripts for degradation through nonsense-mediated decay (NMD). This differs from frameshift mutations caused by small insertions or deletions during splicing, which can also introduce premature stop codons but do not always trigger transcript degradation by NMD, and may allow some protein production from the altered transcripts [14,15,16][14][15][16]. Considering that NMD might decline with aging [17], this might affect the levels and impact of aging-related alternative splicing isoforms.
In addition, it has been observed that mutations within splice sites may activate cryptic splice sites, resulting in the erroneous processing of lamin A, a gene associated with laminopathies and implicated in premature aging and other aging-related disorders [18].

2. Age-Related Alterations in Splicing

The multifaceted process of aging is linked to a progressive loss in physiological integrity, which causes functional decline and elevated morbidity. Aging can alter the balance of the proteins produced by a particular gene [22,23][19][20]. This phenomenon may be considered as an evolved response to let cells change their transcriptome and proteome to adapt to the new condition. From this point of view, age-related changes in alternative splicing can contribute to and add a new degree of complexity to the control of gene expression (Figure 1). On the other hand, the age-dependent variations in alternative splicing may be considered the negative side-effect of a progressive deterioration in quality control of the splicing machinery (Figure 1), in a similar manner as has been observed at the proteomic level [24,25][21][22]. Growing evidence suggests that aging is associated with changes in splicing fidelity, primarily intron retention [26][23], a phenomenon conserved through evolution [26,27,28][23][24][25]. However, it is unclear if this is a result of aging-related disruptions in cellular homeostasis or a cause. Intriguingly, genes involved in metabolic processes exhibit intron inclusion with age, and dietary restriction induces intron retention in young organisms like Caenorhabditis elegans [27][24] and Drosophila heads [26][23], and in the hippocampus of mice [16]. In addition, an increase in age-related intron retention in genes implicated in proteins and mRNA homeostasis has been correlated with aging-associated diseases, such as Alzheimer’s disease patients [26][23]. Other studies have then showed that exon skipping is prevalent in aging skeletal muscle, particularly in genes tied to mitochondrial functions and inflammation [29][26]. Additionally, a comparison of splicing types across tissues showed a bias towards intron retention upregulation and identified cassette exons as another frequent event [20][27]. These observations emphasize that age-related changes in alternative splicing contribute to the complexity of aging. Aging is a multifaceted process associated with the progressive loss of physiological integrity, leading to functional decline and increased morbidity. These observations highlight that age-related changes in alternative splicing contribute to the complexity of the aging process. In conclusion, splicing changes are a dynamic and complex aspect of the aging process, involving various splicing events and tissue-specific effects, and underscore the importance of further research to elucidate the mechanisms and functional consequences of age-related splicing alterations that may provide insights into potential therapeutic strategies to mitigate age-related health issues.
Figure 1. Schematic diagram of the main aging-related alternative splicing events. Most genes are split between exons and introns. Splicing-defective or premature termination codon (PTC)-containing transcripts are retained within nucleus, with inhibition of translation (a). Normal patterns of splice site selection (indicated with solid black lines) join the constitutive exons together to create “wild type” mRNAs (b). Intron-retaining transcripts can include a PTC and undergo degradation by activation of nonsense-mediated decay (c). The inclusion of a cassette exon into mRNA (indicated with dashed black lines) can lead to a gain of functional domains (d) or to the appearance of a PTC (e). The inclusion of a cryptic exon into mRNA can lead to the introduction of frameshifts or PTC and subsequently to the loss of specific domains or to reduction in gene expression (f). A portion of PTC-containing transcripts is recognized and retained in the nucleus before they have a chance to be exported to the cytoplasm for degradation by the NMD system. PTCs in different reading frames can lead to different levels of nuclear retention. This suggests that the mechanism of nuclear retention is not simply due to the presence of a stop codon, but is dependent on the specific sequence context of the PTC [30,31][28][29]. The exact mechanisms by which PTC-containing transcripts are retained in the nucleus are still being investigated. One possible mechanism is alternative splicing—the presence of a PTC can affect the splicing of an mRNA, leading to the inclusion of exons that contain nuclear retention signals that prevent export to the cytoplasm. Another possibility is interaction with specific nuclear proteins or RNA binding proteins that bind to the PTC-containing transcripts and retain them in the nucleus, blocking their export. Changes to the mRNA structure induced by the PTC could also prevent transit to the cytoplasm if the folding prevents export. While further research is needed to elucidate the precise retention mechanisms, the nuclear retention itself may serve a protective purpose. By retaining PTC-containing transcripts in the nucleus, truncated proteins are prevented from being translated in the cytoplasm where they could have detrimental effects on the cell [31,32][29][30]. Thus, nuclear retention may act more to protect the cell rather than facilitate mRNA repair pathways like splicing to excise the PTC or induce degradation of unrepairable mRNAs. Yellow box: constitutive exon; gray box: cryptic exon; aqua box: cassette exon; asterisk: premature termination codon.

3. Mining Databases for Splicing Factors Linked to Human Aging

Various available resources currently aim to support research on the genetics of human aging [135,136,137,138,139][31][32][33][34][35]. The investigation revealed an overlap of 50 genes with the list of genes that either show increased or decreased expression during replicative senescence of human cells (Table 1).
Table 1. Overlap between the genes categorized under Gene Ontology ID 0008380 and the list of genes that either show increased or decreased expression during replicative senescence of human cells available in the CellAge Database (https://genomics.senescence.info/cells/, accessed on 11 December 2023). The table presents the results of matching the 1159 human orthologs of RNA binding proteins categorized under Gene Ontology ID 0008380 with the genes listed in the CellAge database. The trends of expression (over- or under-expression) associated with aging for these genes, as well as the effects (induction or inhibition) of these changes on the senescent phenotype, are shown.
Gene Symbol Expression Senescence Effect
AHNAK2 Over-expressed  
RBM24 Over-expressed  
ALYREF Under-expressed  
BUD13 Under-expressed  
C1QBP Under-expressed  
CWF19L1 Under-expressed  
DAZAP1 Under-expressed  
DCPS Under-expressed  
DDX39A Under-expressed  
DHX15 Under-expressed  
EIF4A3 Under-expressed  
FUS Under-expressed  
GEMIN6 Under-expressed  
HNRNPA1 Under-expressed Inhibits
HNRNPA2B1 Under-expressed  
HNRNPA3 Under-expressed Inhibits
HNRNPC Under-expressed Induces
HNRNPF Under-expressed  
HNRNPH1 Under-expressed  
HNRNPH3 Under-expressed  
HNRNPM Under-expressed  
HNRNPU Under-expressed  
KHDRBS1 Under-expressed  
KHSRP Under-expressed  
LSM2 Under-expressed  
LSM3 Under-expressed  
LSM5 Under-expressed  
LSM6 Under-expressed  
NPM1 Under-expressed Inhibits
PRPF38A Under-expressed  
PRPF4 Under-expressed  
PTBP1 Under-expressed  
RBMX Under-expressed  
RSRC1 Under-expressed  
SF3B3 Under-expressed  
SFPQ Under-expressed  
SNRNP40 Under-expressed  
SNRPA Under-expressed  
SNRPB Under-expressed  
SNRPB2 Under-expressed  
SNRPC Under-expressed  
SNRPD1 Under-expressed  
SNRPE Under-expressed  
SNRPF Under-expressed  
SRSF3 Under-expressed  
SRSF7 Under-expressed  
SYNCRIP Under-expressed  
THOC1 Under-expressed  
TRA2B Under-expressed  
TSEN15 Under-expresse
 The intersection of splicing-related genes with cellular senescence presents a compelling connection, suggesting that the splicing machinery and the intricate regulation of gene expression through splicing may have a significant role in the senescence process. This association underscores the potential influence of RNA processing on the mechanisms governing aging and cellular senescence.
The intersection of splicing-related genes with cellular senescence presents a compelling connection, suggesting that the splicing machinery and the intricate regulation of gene expression through splicing may have a significant role in the senescence process. This association underscores the potential influence of RNA processing on the mechanisms governing aging and cellular senescence.
However, it is crucial to recognize that the interplay between genes and biological processes is far from straightforward. The complexity of these relationships is exemplified in this analysis. Splicing-related genes are not uniform in their senescence-related effects; rather, they exhibit a range of roles. Some of these genes may act as activators of senescence, while others serve as inhibitors, indicating a nuanced interplay within the cellular context. The majority of these genes display under-expression during replicative senescence. This phenomenon suggests that these genes are subject to downregulation as cells progress towards replicative senescence, aligning with the established notion that changes in gene expression are a hallmark of cellular senescence.
Remarkably, the analysis also brought to light the presence of two genes, AHNAK2 and RBM24, which buck the trend by being over-expressed during replicative senescence. This discovery is particularly intriguing as it emphasizes that while downregulation of splicing-related genes is a common theme, there exist specific genes that undergo an increase in expression as senescence sets in. As such, further exploration of the roles played by AHNAK2 and RBM24 in senescence holds the promise of shedding light on the underlying molecular mechanisms.
The observation that splicing-related genes exhibit differential expression during senescence further substantiates the connection between splicing and the senescence process. This connection is reinforced by the understanding that alternative splicing is a pivotal step in the regulation of gene expression. Dysregulation of this process can have far-reaching effects, potentially impacting the transcriptome and proteome, and in turn, influencing pathways linked to senescence.
The intriguing aspect of a significant number of splicing-related genes experiencing under-expression during replicative senescence hints at the possibility of a broad-scale suppression of splicing machinery. This suppression could, in turn, impact the processing of pre-mRNA and the synthesis of functional proteins, ultimately leading to altered cellular functions and contributing to the senescence phenotype.
On the other hand, the analysis categorically outlines the associations of identified splicing-related genes with senescence induction or inhibition. Notably, HNRNPA1, HNRNPA3, and NPM1 are under-expressed and are associated with the inhibition of senescence. In contrast, hnRNPC stands out as the only splicing-related factor associated with senescence induction, despite being under-expressed. These observations underscore the intricacy of cellular senescence and emphasize the multifaceted roles of various genes in the regulation of this process. They underscore the notion that senescence is a delicately balanced phenomenon influenced by numerous genetic and molecular factors.
Understanding the roles of these splicing factors in senescence opens the door to potential clinical implications. Notably, if specific factors are linked to senescence induction and possess established roles in the process, they might be considered as viable targets for interventions aimed at modulating senescence. Such interventions hold promise in addressing aging-related conditions and age-related diseases, making this field of research highly relevant and potentially transformative.

References

  1. Johnson, F.B.; Sinclair, D.A.; Guarente, L. Molecular Biology of Aging. Cell 1999, 96, 291–302.
  2. Liu, Y.; Gonzàlez-Porta, M.; Santos, S.; Brazma, A.; Marioni, J.C.; Aebersold, R.; Venkitaraman, A.R.; Wickramasinghe, V.O. Impact of Alternative Splicing on the Human Proteome. Cell Rep. 2017, 20, 1229–1241.
  3. Kim, E.; Magen, A.; Ast, G. Different Levels of Alternative Splicing among Eukaryotes. Nucleic Acids Res. 2007, 35, 125–131.
  4. Lee, Y.; Rio, D.C. Mechanisms and Regulation of Alternative Pre-mRNA Splicing. Annu. Rev. Biochem. 2015, 84, 291–323.
  5. Somel, M.; Guo, S.; Fu, N.; Yan, Z.; Hu, H.Y.; Xu, Y.; Yuan, Y.; Ning, Z.; Hu, Y.; Menzel, C.; et al. MicroRNA, mRNA, and Protein Expression Link Development and Aging in Human and Macaque Brain. Genome Res. 2010, 20, 1207–1218.
  6. Holly, A.C.; Melzer, D.; Pilling, L.C.; Fellows, A.C.; Tanaka, T.; Ferrucci, L.; Harries, L.W. Changes in Splicing Factor Expression Are Associated with Advancing Age in Man. Mech. Ageing Dev. 2013, 134, 356–366.
  7. Lee, B.P.; Pilling, L.C.; Emond, F.; Flurkey, K.; Harrison, D.E.; Yuan, R.; Peters, L.L.; Kuchel, G.A.; Ferrucci, L.; Melzer, D.; et al. Changes in the Expression of Splicing Factor Transcripts and Variations in Alternative Splicing Are Associated with Lifespan in Mice and Humans. Aging Cell 2016, 15, 903–913.
  8. Wood, S.H.; Craig, T.; Li, Y.; Merry, B.; de Magalhães, J.P. Whole Transcriptome Sequencing of the Aging Rat Brain Reveals Dynamic RNA Changes in the Dark Matter of the Genome. Age 2013, 35, 763–776.
  9. Harries, L.W.; Hernandez, D.; Henley, W.; Wood, A.; Holly, A.C.; Bradley-Smith, R.M.; Yaghootkar, H.; Dutta, A.; Murray, A.; Frayling, T.M.; et al. Human Aging Is Characterized by Focused Changes in Gene Expression and Deregulation of Alternative Splicing. Aging Cell 2011, 10, 868–878.
  10. Mazin, P.; Xiong, J.; Liu, X.; Yan, Z.; Zhang, X.; Li, M.; He, L.; Somel, M.; Yuan, Y.; Phoebe Chen, Y.-P.; et al. Widespread Splicing Changes in Human Brain Development and Aging. Mol. Syst. Biol. 2013, 9, 633.
  11. Tollervey, J.R.; Wang, Z.; Hortobágyi, T.; Witten, J.T.; Zarnack, K.; Kayikci, M.; Clark, T.A.; Schweitzer, A.C.; Rot, G.; Curk, T.; et al. Analysis of Alternative Splicing Associated with Aging and Neurodegeneration in the Human Brain. Genome Res. 2011, 21, 1572–1582.
  12. Peffers, M.J.; Fang, Y.; Cheung, K.; Wei, T.K.J.; Clegg, P.D.; Birch, H.L. Transcriptome Analysis of Ageing in Uninjured Human Achilles Tendon. Arthritis Res. Ther. 2015, 17, 33.
  13. Swindell, W.R.; Johnston, A.; Sun, L.; Xing, X.; Fisher, G.J.; Bulyk, M.L.; Elder, J.T.; Gudjonsson, J.E. Meta-Profiles of Gene Expression during Aging: Limited Similarities between Mouse and Human and an Unexpectedly Decreased Inflammatory Signature. PLoS ONE 2012, 7, e33204.
  14. Maquat, L.E.; Kinniburgh, A.J.; Rachmilewitz, E.A.; Ross, J. Unstable Beta-Globin mRNA in mRNA-Deficient Beta o Thalassemia. Cell 1981, 27, 543–553.
  15. Losson, R.; Lacroute, F. Interference of Nonsense Mutations with Eukaryotic Messenger RNA Stability. Proc. Natl. Acad. Sci. USA 1979, 76, 5134–5137.
  16. Tabrez, S.S.; Sharma, R.D.; Jain, V.; Siddiqui, A.A.; Mukhopadhyay, A. Differential Alternative Splicing Coupled to Nonsense-Mediated Decay of mRNA Ensures Dietary Restriction-Induced Longevity. Nat. Commun. 2017, 8, 306.
  17. Son, H.G.; Seo, M.; Ham, S.; Hwang, W.; Lee, D.; An, S.W.A.; Artan, M.; Seo, K.; Kaletsky, R.; Arey, R.N.; et al. RNA Surveillance via Nonsense-Mediated mRNA Decay Is Crucial for Longevity in Daf-2/Insulin/IGF-1 Mutant C. elegans. Nat. Commun. 2017, 8, 14749.
  18. Coppedè, F. Mutations Involved in Premature-Ageing Syndromes. Appl. Clin. Genet. 2021, 14, 279–295.
  19. Anisimova, A.S.; Meerson, M.B.; Gerashchenko, M.V.; Kulakovskiy, I.V.; Dmitriev, S.E.; Gladyshev, V.N. Multifaceted Deregulation of Gene Expression and Protein Synthesis with Age. Proc. Natl. Acad. Sci. USA 2020, 117, 15581–15590.
  20. Stegeman, R.; Weake, V.M. Transcriptional Signatures of Aging. J. Mol. Biol. 2017, 429, 2427–2437.
  21. Anisimova, A.S.; Alexandrov, A.I.; Makarova, N.E.; Gladyshev, V.N.; Dmitriev, S.E. Protein Synthesis and Quality Control in Aging. Aging 2018, 10, 4269–4288.
  22. Stoeger, T.; Grant, R.A.; McQuattie-Pimentel, A.C.; Anekalla, K.R.; Liu, S.S.; Tejedor-Navarro, H.; Singer, B.D.; Abdala-Valencia, H.; Schwake, M.; Tetreault, M.-P.; et al. Aging Is Associated with a Systemic Length-Associated Transcriptome Imbalance. Nat. Aging 2022, 2, 1191–1206.
  23. Adusumalli, S.; Ngian, Z.-K.; Lin, W.-Q.; Benoukraf, T.; Ong, C.-T. Increased Intron Retention Is a Post-Transcriptional Signature Associated with Progressive Aging and Alzheimer’s Disease. Aging Cell 2019, 18, e12928.
  24. Heintz, C.; Doktor, T.K.; Lanjuin, A.; Escoubas, C.; Zhang, Y.; Weir, H.J.; Dutta, S.; Silva-García, C.G.; Bruun, G.H.; Morantte, I.; et al. Splicing Factor 1 Modulates Dietary Restriction and TORC1 Pathway Longevity in C. elegans. Nature 2017, 541, 102–106.
  25. Rollins, J.A.; Shaffer, D.; Snow, S.S.; Kapahi, P.; Rogers, A.N. Dietary Restriction Induces Posttranscriptional Regulation of Longevity Genes. Life Sci. Alliance 2019, 2, e201800281.
  26. Ubaida-Mohien, C.; Lyashkov, A.; Gonzalez-Freire, M.; Tharakan, R.; Shardell, M.; Moaddel, R.; Semba, R.D.; Chia, C.W.; Gorospe, M.; Sen, R.; et al. Discovery Proteomics in Aging Human Skeletal Muscle Finds Change in Spliceosome, Immunity, Proteostasis and Mitochondria. eLife 2019, 8, e49874.
  27. Wang, K.; Wu, D.; Zhang, H.; Das, A.; Basu, M.; Malin, J.; Cao, K.; Hannenhalli, S. Comprehensive Map of Age-Associated Splicing Changes across Human Tissues and Their Contributions to Age-Associated Diseases. Sci. Rep. 2018, 8, 10929.
  28. Shi, M.; Zhang, H.; Wang, L.; Zhu, C.; Sheng, K.; Du, Y.; Wang, K.; Dias, A.; Chen, S.; Whitman, M.; et al. Premature Termination Codons Are Recognized in the Nucleus in A Reading-Frame Dependent Manner. Cell Discov. 2015, 1, 15001.
  29. Jacob, A.G.; Smith, C.W.J. Intron Retention as a Component of Regulated Gene Expression Programs. Hum. Genet. 2017, 136, 1043–1057.
  30. Monteuuis, G.; Wong, J.J.L.; Bailey, C.G.; Schmitz, U.; Rasko, J.E.J. The Changing Paradigm of Intron Retention: Regulation, Ramifications and Recipes. Nucleic Acids Res. 2019, 47, 11497–11513.
  31. Tacutu, R.; Thornton, D.; Johnson, E.; Budovsky, A.; Barardo, D.; Craig, T.; Diana, E.; Lehmann, G.; Toren, D.; Wang, J.; et al. Human Ageing Genomic Resources: New and Updated Databases. Nucleic Acids Res. 2018, 46, D1083–D1090.
  32. de Magalhães, J.P.; Budovsky, A.; Lehmann, G.; Costa, J.; Li, Y.; Fraifeld, V.; Church, G.M. The Human Ageing Genomic Resources: Online Databases and Tools for Biogerontologists. Aging Cell 2009, 8, 65–72.
  33. Aging Atlas Consortium. Aging Atlas: A Multi-Omics Database for Aging Biology. Nucleic Acids Res. 2021, 49, D825–D830.
  34. Chatsirisupachai, K.; Palmer, D.; Ferreira, S.; de Magalhães, J.P. A Human Tissue-Specific Transcriptomic Analysis Reveals a Complex Relationship between Aging, Cancer, and Cellular Senescence. Aging Cell 2019, 18, e13041.
  35. Avelar, R.A.; Ortega, J.G.; Tacutu, R.; Tyler, E.J.; Bennett, D.; Binetti, P.; Budovsky, A.; Chatsirisupachai, K.; Johnson, E.; Murray, A.; et al. A Multidimensional Systems Biology Analysis of Cellular Senescence in Aging and Disease. Genome Biol. 2020, 21, 91.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/)
ScholarVision Creations
Feedback